Faster access than browser!
17 relations: AM-2201, APICA (synthetic cannabinoid drug), Controlled Substances Act, Designer drug, Drug Enforcement Administration, Drugs controlled by the German Betäubungsmittelgesetz, EC50, JWH-018, Ohio, QUCHIC, Structural analog, Structure–activity relationship, STS-135 (drug), Synthetic cannabinoids, UR-144, XLR-11, 5F-PB-22.
AM-2201
AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole) is a recreational designer drug that acts as a potent but nonselective full agonist for the cannabinoid receptor.
New!!: PB-22 and AM-2201 · See more »
APICA (synthetic cannabinoid drug)
APICA (2NE1, SDB-001, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide) is an indole based drug that acts as a potent agonist for the cannabinoid receptors.
New!!: PB-22 and APICA (synthetic cannabinoid drug) · See more »
Controlled Substances Act
The Controlled Substances Act (CSA) is the statute establishing federal U.S. drug policy under which the manufacture, importation, possession, use, and distribution of certain substances is regulated.
New!!: PB-22 and Controlled Substances Act · See more »
Designer drug
A designer drug is a structural or functional analog of a controlled substance that has been designed to mimic the pharmacological effects of the original drug, while avoiding classification as illegal and/or detection in standard drug tests.
New!!: PB-22 and Designer drug · See more »
Drug Enforcement Administration
The Drug Enforcement Administration (DEA) is a United States federal law enforcement agency under the United States Department of Justice, tasked with combating drug smuggling and use within the United States.
New!!: PB-22 and Drug Enforcement Administration · See more »
Drugs controlled by the German Betäubungsmittelgesetz
Drugs controlled by the German Betäubungsmittelgesetz (BtMG).
New!!: PB-22 and Drugs controlled by the German Betäubungsmittelgesetz · See more »
EC50
Half maximal effective concentration (EC50) refers to the concentration of a drug, antibody or toxicant which induces a response halfway between the baseline and maximum after a specified exposure time.
New!!: PB-22 and EC50 · See more »
JWH-018
JWH-018 (1-pentyl-3-(1-naphthoyl)indole) or AM-678 is an analgesic chemical from the naphthoylindole family that acts as a full agonist at both the CB1 and CB2 cannabinoid receptors, with some selectivity for CB2.
New!!: PB-22 and JWH-018 · See more »
Ohio
Ohio is a Midwestern state in the Great Lakes region of the United States.
New!!: PB-22 and Ohio · See more »
QUCHIC
QUCHIC (BB-22 or 1-(cyclohexylmethyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester) is a designer drug offered by online vendors as a cannabimimetic agent, and was first detected being sold in synthetic cannabis products in Japan in early 2013, and subsequently also in New Zealand.
New!!: PB-22 and QUCHIC · See more »
Structural analog
A structural analog, also known as a chemical analog or simply an analog, is a compound having a structure similar to that of another compound, but differing from it in respect to a certain component.
New!!: PB-22 and Structural analog · See more »
Structure–activity relationship
commented out as it doesn't appear to be immediately relevant & it is in the wrong place if it is relevant-->The structure–activity relationship (SAR) is the relationship between the chemical or 3D structure of a molecule and its biological activity.
New!!: PB-22 and Structure–activity relationship · See more »
STS-135 (drug)
STS-135 (N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide, also called 5F-APICA) is a designer drug offered by online vendors as a cannabimimetic agent.
New!!: PB-22 and STS-135 (drug) · See more »
Synthetic cannabinoids
Synthetic cannabinoids are a class of molecules that bind to cannabinoid receptors in the body–the same receptors that the cannabinoids in cannabis plants, such as THC and CBD–attach to.
New!!: PB-22 and Synthetic cannabinoids · See more »
UR-144
UR-144 (TMCP-018, KM-X1, MN-001, YX-17) is a drug invented by Abbott Laboratories, that acts as a selective full agonist of the peripheral cannabinoid receptor CB2, but with much lower affinity for the psychoactive CB1 receptor.
New!!: PB-22 and UR-144 · See more »
XLR-11
XLR-11 (5"-fluoro-UR-144) is a drug that acts as a potent agonist for the cannabinoid receptors CB1 and CB2 with EC50 values of 98 nM and 83 nM, respectively.
New!!: PB-22 and XLR-11 · See more »
5F-PB-22
5F-PB-22 (5F-QUPIC or Quinolin-8-yl 1-pentyfluoro-1H-indole-3-8-carboxylate) is a designer drug which acts as a cannabinoid agonist.
New!!: PB-22 and 5F-PB-22 · See more »
